Alamar Biosciences, Inc. (ALMR) vs Harmony Biosciences Holdings, Inc. (HRMY)
A side-by-side comparison of Alamar Biosciences, Inc. and Harmony Biosciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$34.69HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
HRMY
Harmony Biosciences Holdings, Inc.
$39.78HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ALMR vs HRMY
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)HRMY +35.7% (+35.7%/yr)ALMR compounded faster over this window
ALMR HRMY
ALMR vs HRMY: by the numbers
- •ALMR is the larger company ($2.40B vs $2.30B market cap).
- •HRMY is profitable (18.88% net margin) while ALMR runs a net loss (-40.18%).
Metrics side by side
Valuation
| Metric | ALMR | HRMY |
|---|---|---|
| P/E ratio | N/A | 12.91 |
| Forward P/E | N/A | 10.09 |
| P/S ratio | N/A | 2.40 |
| P/B ratio | 7.68 | 2.30 |
| EV / EBITDA | N/A | 7.45 |
| FCF yield | N/A | 15.41% |
Profitability
| Metric | ALMR | HRMY |
|---|---|---|
| Gross margin | 56.20% | 75.42% |
| Operating margin | -42.22% | 24.03% |
| Net margin | -40.18% | 18.88% |
| ROE | N/A | 18.14% |
| ROIC | -26.95% | 14.96% |
Growth (annualized)
| Metric | ALMR | HRMY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 32.47% |
| FCF CAGR (5Y) | N/A | 48.43% |
| Total return CAGR (5Y) | N/A | 0.91% |
Frequently asked
- Is ALMR or HRMY more profitable?
- HRMY runs the higher net margin — ALMR at -40.18% versus HRMY at 18.88%.
Go deeper
Dig into the metrics
Harmony Biosciences P/E ratioAlamar Biosciences ROEHarmony Biosciences ROEAlamar Biosciences operating marginHarmony Biosciences operating marginAlamar Biosciences revenue growthHarmony Biosciences revenue growthAlamar Biosciences free cash flowHarmony Biosciences free cash flow
Alamar Biosciences & Harmony Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.